Birchmere Ventures

Birchmere Ventures is a private equity and venture capital firm established in 1996 and headquartered in Pittsburgh, Pennsylvania. The firm specializes in early-stage investments across various sectors, including clean technology, healthcare, and technology. Over the past two decades, Birchmere has successfully supported the growth of numerous companies, including those in event management, education technology, and B2B marketplaces. The firm is dedicated to identifying promising businesses throughout North America that may be overlooked by other investors, focusing on innovative solutions in software, healthcare services, cybersecurity, and big data. By leveraging its experience and insights, Birchmere Ventures aims to help these companies scale effectively, recognizing that talent and potential can be found beyond traditional coastal hubs.

Ivan Koon

Venture Partner

Sean Sebastian

Partner

Past deals in Pennsylvania

Idelic

Series B in 2021
Idelic is a software solutions provider based in Pittsburgh, Pennsylvania, specializing in the transportation industry, particularly for commercial trucking fleets. Founded in 2016, the company offers a driver management and analytics platform designed to enhance driver safety. By integrating data from various technology sources into a unified system, Idelic enables its clients to gain predictive insights and effectively manage their safety operations. This approach helps transportation fleets identify at-risk drivers and take proactive measures to prevent accidents before they occur.

Aspinity

Series A in 2020
Aspinity, Inc. specializes in the manufacturing of reconfigurable analog modular processor (RAMP) chips designed for ultra-low-power electronics. These compact, analog machine learning chips analyze raw, unstructured sensor data, enabling them to identify important data early in the signal chain while filtering out background noise. By processing analog data directly, Aspinity's technology reduces the need for higher-power processing of insignificant information, optimizing power consumption for always-on, battery-operated devices. Their innovations are particularly valuable in applications such as voice activation, industrial machine health monitoring, and wearable health devices across consumer, industrial, and biomedical markets. Founded in 2015 and based in Pittsburgh, Pennsylvania, Aspinity aims to enhance battery life in sensing applications without compromising performance.

Idelic

Series A in 2019
Idelic is a software solutions provider based in Pittsburgh, Pennsylvania, specializing in the transportation industry, particularly for commercial trucking fleets. Founded in 2016, the company offers a driver management and analytics platform designed to enhance driver safety. By integrating data from various technology sources into a unified system, Idelic enables its clients to gain predictive insights and effectively manage their safety operations. This approach helps transportation fleets identify at-risk drivers and take proactive measures to prevent accidents before they occur.

Ikos

Venture Round in 2019
Ikos Holdings Co. operates an online platform that connects landlords and renters, streamlining the rental experience for both parties. Founded in 2017 and based in Pittsburgh, Pennsylvania, the company offers a flexible on-demand leasing service for investors while utilizing data analysis to guide client investments. By simplifying the rental process, Ikos helps landlords and renters make informed decisions, fostering transparency and adaptability in their interactions. The platform aims to enhance the way individuals engage with rental properties, ultimately benefiting the real estate market.

Idelic

Seed Round in 2018
Idelic is a software solutions provider based in Pittsburgh, Pennsylvania, specializing in the transportation industry, particularly for commercial trucking fleets. Founded in 2016, the company offers a driver management and analytics platform designed to enhance driver safety. By integrating data from various technology sources into a unified system, Idelic enables its clients to gain predictive insights and effectively manage their safety operations. This approach helps transportation fleets identify at-risk drivers and take proactive measures to prevent accidents before they occur.

Aspinity

Seed Round in 2018
Aspinity, Inc. specializes in the manufacturing of reconfigurable analog modular processor (RAMP) chips designed for ultra-low-power electronics. These compact, analog machine learning chips analyze raw, unstructured sensor data, enabling them to identify important data early in the signal chain while filtering out background noise. By processing analog data directly, Aspinity's technology reduces the need for higher-power processing of insignificant information, optimizing power consumption for always-on, battery-operated devices. Their innovations are particularly valuable in applications such as voice activation, industrial machine health monitoring, and wearable health devices across consumer, industrial, and biomedical markets. Founded in 2015 and based in Pittsburgh, Pennsylvania, Aspinity aims to enhance battery life in sensing applications without compromising performance.

LegalSifter

Venture Round in 2017
LegalSifter, Inc. is a company that specializes in artificial intelligence solutions for contract document reviews. Founded in 2013 and based in Pittsburgh, Pennsylvania, the company offers two primary Software-as-a-Service products: LegalSifter, designed for document review, and ContractSifter, focused on contract extraction. Utilizing natural language processing and machine learning, LegalSifter transforms unstructured legal language into structured data and insights, aiding in-house counsel teams, legal operations, law firms, and various corporate leaders in managing legal obligations. The platform combines AI with human expertise to provide contract advice, thereby reducing risks and enhancing safety in the contract negotiation process.

JazzHR

Series D in 2017
JazzHR is a user-friendly and affordable recruiting software designed specifically for small to medium-sized businesses. The platform replaces outdated hiring methods, such as email and spreadsheets, with an intuitive applicant tracking system that streamlines the recruitment process. It offers features such as candidate sourcing and employer branding, enabling recruiters and hiring managers to build an effective and scalable hiring strategy. Since its inception in 2009, JazzHR has assisted thousands of companies in filling over 100,000 positions. Additionally, it has introduced an integrated crowd-sourcing and predictive analytics initiative known as the Crowd, further enhancing its capabilities in talent acquisition.

Idelic

Seed Round in 2017
Idelic is a software solutions provider based in Pittsburgh, Pennsylvania, specializing in the transportation industry, particularly for commercial trucking fleets. Founded in 2016, the company offers a driver management and analytics platform designed to enhance driver safety. By integrating data from various technology sources into a unified system, Idelic enables its clients to gain predictive insights and effectively manage their safety operations. This approach helps transportation fleets identify at-risk drivers and take proactive measures to prevent accidents before they occur.

ALung

Series C in 2017
ALung Technologies, Inc. is a medical device company based in Pittsburgh, Pennsylvania, specializing in the development and manufacturing of devices for treating acute respiratory failure. The company's primary product, the Hemolung Respiratory Assist System, serves as a dialysis-like alternative to mechanical ventilation by removing carbon dioxide and delivering oxygen directly into the blood. This technology allows patients' lungs to rest and recover while avoiding the need for intubation and enabling protective ventilation. In addition to the Hemolung system, ALung Technologies also develops the Hattler Catheter, which facilitates extracorporeal gas exchange by circulating blood through a small catheter inserted into the central venous bloodstream. Founded in 1997, the company focuses on innovative solutions for both acute and chronic respiratory disorders.

Ikos

Seed Round in 2017
Ikos Holdings Co. operates an online platform that connects landlords and renters, streamlining the rental experience for both parties. Founded in 2017 and based in Pittsburgh, Pennsylvania, the company offers a flexible on-demand leasing service for investors while utilizing data analysis to guide client investments. By simplifying the rental process, Ikos helps landlords and renters make informed decisions, fostering transparency and adaptability in their interactions. The platform aims to enhance the way individuals engage with rental properties, ultimately benefiting the real estate market.

Encentiv Energy

Series A in 2016
Encentiv Energy LLC operates a platform designed to enhance participation in energy efficiency programs for utilities, energy efficiency vendors, finance companies, and non-residential customers. The company's flagship offering, Encentivizer, is a national incentive management platform that simplifies access to local electric utility rebates, incentives, and funding solutions. It helps identify relevant programs to connect financial resources to customers' new construction and renovation projects while providing energy advisory and project financing services. Encentivizer leverages extensive data on energy efficiency products and utility incentives, enabling stakeholders to make informed decisions that lead to significant energy consumption reductions. Founded in 2009 and based in Pittsburgh, Pennsylvania, Encentiv Energy was previously known as AllFacilities Energy Group, LLC before rebranding in 2013.

Identified Technologies

Venture Round in 2016
Identified Technologies Corporation specializes in developing self-piloting aerial mapping and land survey drones, providing comprehensive data scanning, capture, and analytics solutions. Founded in 2013 and headquartered in Pittsburgh, Pennsylvania, the company offers a range of services that enhance project visibility and productivity for industries such as energy, mining, manufacturing, and construction. Its platform enables users to conduct 3D volumetric analysis, create 2D measurements, and generate detailed maps, while also ensuring FAA compliance and streamlined flight planning. The technology facilitates continuous job site monitoring, allowing clients to perform as-built versus planned comparisons and track project progress, ultimately improving profitability and operational efficiency.

SubCentral

Seed Round in 2016
SubCentral, Inc. is a company based in Pittsburgh that specializes in subscription management tools for small and mid-sized businesses. Founded in 2015 by Jason Yablinsky, SubCentral provides a platform that enables organizations to efficiently organize and manage their cloud software subscriptions from a single hub. The company's services encompass Software-as-a-Service access, provisioning, password management, analytics, usage tracking, and billing tools, all designed to facilitate the online management of Software-as-a-Service and related products.

ContainerShip

Seed Round in 2016
Containership, Inc. owns and operates a cloud based Platform-as-a-Service and continuous delivery system for containers. It offers an open source Docker hosting platform that provides application deployment, cluster scheduling, and service discovery; and hosted service, which includes automated provisioning, marketplace integrations, load balancing, and cluster snapshots. The company was incorporated in 2015 and is based in Pittsburgh, Pennsylvania.

Treatspace

Venture Round in 2015
Treatspace, Inc. is a healthcare platform based in Pittsburgh, Pennsylvania, established in 2012. The platform enhances online relationships among healthcare professionals, medical practices, hospitals, and patients. It offers several networks, including Lifesaving Health Networks, which connects patients and physicians, and a Referral Network that streamlines referral management for primary care practices and specialists. Additionally, the Clinical Network fosters collaboration among clinicians. Treatspace provides accurate and verifiable information about healthcare practices, enabling patients to access trustworthy details about their doctors. By improving patient engagement and facilitating clinical collaboration, Treatspace transforms the processes of referral management and care coordination in primary care, specialty care, and hospital systems.

Identified Technologies

Seed Round in 2015
Identified Technologies Corporation specializes in developing self-piloting aerial mapping and land survey drones, providing comprehensive data scanning, capture, and analytics solutions. Founded in 2013 and headquartered in Pittsburgh, Pennsylvania, the company offers a range of services that enhance project visibility and productivity for industries such as energy, mining, manufacturing, and construction. Its platform enables users to conduct 3D volumetric analysis, create 2D measurements, and generate detailed maps, while also ensuring FAA compliance and streamlined flight planning. The technology facilitates continuous job site monitoring, allowing clients to perform as-built versus planned comparisons and track project progress, ultimately improving profitability and operational efficiency.

JazzHR

Series C in 2014
JazzHR is a user-friendly and affordable recruiting software designed specifically for small to medium-sized businesses. The platform replaces outdated hiring methods, such as email and spreadsheets, with an intuitive applicant tracking system that streamlines the recruitment process. It offers features such as candidate sourcing and employer branding, enabling recruiters and hiring managers to build an effective and scalable hiring strategy. Since its inception in 2009, JazzHR has assisted thousands of companies in filling over 100,000 positions. Additionally, it has introduced an integrated crowd-sourcing and predictive analytics initiative known as the Crowd, further enhancing its capabilities in talent acquisition.

NoWait

Series B in 2014
Nowait, Inc. operates a restaurant reservation application that offers an electronic waitlist system and seating tool, allowing consumers to join queues at restaurants using their smartphones. Founded in 2010 and based in Pittsburgh, Pennsylvania, the company aims to enhance dining experiences by streamlining various aspects of restaurant management, including waitlists, table turnover, and analytics. By facilitating efficient service, Nowait enables guests to save time while accessing a network of restaurants across the United States. As of early 2017, Nowait functions as a subsidiary of Yelp Inc.

ALung

Series B in 2013
ALung Technologies, Inc. is a medical device company based in Pittsburgh, Pennsylvania, specializing in the development and manufacturing of devices for treating acute respiratory failure. The company's primary product, the Hemolung Respiratory Assist System, serves as a dialysis-like alternative to mechanical ventilation by removing carbon dioxide and delivering oxygen directly into the blood. This technology allows patients' lungs to rest and recover while avoiding the need for intubation and enabling protective ventilation. In addition to the Hemolung system, ALung Technologies also develops the Hattler Catheter, which facilitates extracorporeal gas exchange by circulating blood through a small catheter inserted into the central venous bloodstream. Founded in 1997, the company focuses on innovative solutions for both acute and chronic respiratory disorders.

JazzHR

Series B in 2012
JazzHR is a user-friendly and affordable recruiting software designed specifically for small to medium-sized businesses. The platform replaces outdated hiring methods, such as email and spreadsheets, with an intuitive applicant tracking system that streamlines the recruitment process. It offers features such as candidate sourcing and employer branding, enabling recruiters and hiring managers to build an effective and scalable hiring strategy. Since its inception in 2009, JazzHR has assisted thousands of companies in filling over 100,000 positions. Additionally, it has introduced an integrated crowd-sourcing and predictive analytics initiative known as the Crowd, further enhancing its capabilities in talent acquisition.

NoWait

Series A in 2012
Nowait, Inc. operates a restaurant reservation application that offers an electronic waitlist system and seating tool, allowing consumers to join queues at restaurants using their smartphones. Founded in 2010 and based in Pittsburgh, Pennsylvania, the company aims to enhance dining experiences by streamlining various aspects of restaurant management, including waitlists, table turnover, and analytics. By facilitating efficient service, Nowait enables guests to save time while accessing a network of restaurants across the United States. As of early 2017, Nowait functions as a subsidiary of Yelp Inc.

ALung

Series B in 2012
ALung Technologies, Inc. is a medical device company based in Pittsburgh, Pennsylvania, specializing in the development and manufacturing of devices for treating acute respiratory failure. The company's primary product, the Hemolung Respiratory Assist System, serves as a dialysis-like alternative to mechanical ventilation by removing carbon dioxide and delivering oxygen directly into the blood. This technology allows patients' lungs to rest and recover while avoiding the need for intubation and enabling protective ventilation. In addition to the Hemolung system, ALung Technologies also develops the Hattler Catheter, which facilitates extracorporeal gas exchange by circulating blood through a small catheter inserted into the central venous bloodstream. Founded in 1997, the company focuses on innovative solutions for both acute and chronic respiratory disorders.

CyOptics

Venture Round in 2011
CyOptics, Inc. specializes in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, catering to access, metro, and long-haul communications systems. The company offers a range of products, including planar lightwave circuits (PLCs) for telecommunications and defense applications, as well as optical components such as transmitters, receivers, and modulators. These products serve as essential technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with radio frequency and optical design, wafer fabrication, and automated assembly and testing for both telecom and non-telecom applications. The company's clientele primarily consists of original equipment manufacturers and sub-system manufacturers in the communications sector. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication operations in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

ALung

Series A in 2010
ALung Technologies, Inc. is a medical device company based in Pittsburgh, Pennsylvania, specializing in the development and manufacturing of devices for treating acute respiratory failure. The company's primary product, the Hemolung Respiratory Assist System, serves as a dialysis-like alternative to mechanical ventilation by removing carbon dioxide and delivering oxygen directly into the blood. This technology allows patients' lungs to rest and recover while avoiding the need for intubation and enabling protective ventilation. In addition to the Hemolung system, ALung Technologies also develops the Hattler Catheter, which facilitates extracorporeal gas exchange by circulating blood through a small catheter inserted into the central venous bloodstream. Founded in 1997, the company focuses on innovative solutions for both acute and chronic respiratory disorders.

Helomics

Series D in 2010
Helomics is a personalized healthcare company based in Pittsburgh, Pennsylvania, specializing in oncology insights and contract research services. The company focuses on six primary cancers: ovarian, breast, pancreatic, colon, lung, and brain. Helomics utilizes its Precision Cellular Analytical Platform and advanced bioinformatics to deliver personalized tumor profiles, aiding physicians in making informed treatment decisions. Its portfolio includes ChemoFx, which helps in selecting effective treatments for gynecologic cancer, and various biomarker tests like BioSpeciFx and GeneFx, designed to evaluate patient tumors at a molecular level. Additionally, Helomics offers tumor profiling services, patient-derived tumor models, and multi-omics assays, enhancing the precision of cancer care. The company collaborates with pharmaceutical and diagnostic firms to improve patient outcomes through tailored diagnostic solutions and insights, ultimately supporting better clinical decision-making in oncology.

NuPathe

Debt Financing in 2010
NuPathe Inc. is a specialty pharmaceutical company dedicated to developing and commercializing innovative therapies for neurological and psychiatric disorders. The company's flagship product is Zecuity, a transdermal system utilizing sumatriptan for the acute treatment of migraines in adults. In addition to Zecuity, NuPathe is advancing a pipeline of product candidates, including NP201, designed for the continuous treatment of Parkinson's disease, and NP202, aimed at the long-term management of schizophrenia and bipolar disorder. Both candidates leverage the company's proprietary Long-Acting Delivery technology, which facilitates extended medication release through biodegradable implants. Founded in 2005 and based in Malvern, Pennsylvania, NuPathe operates as a subsidiary of Teva Pharmaceutical Industries Limited. The company actively seeks partnerships to enhance the commercial potential of its products in the United States and internationally.

Inspired Technologies

Series B in 2009
Inspired Technologies (North Huntingdon, PA) a commercial-stage medical device company focused on auto-titration of oxygen delivery for COPD patients.

Helomics

Venture Round in 2008
Helomics is a personalized healthcare company based in Pittsburgh, Pennsylvania, specializing in oncology insights and contract research services. The company focuses on six primary cancers: ovarian, breast, pancreatic, colon, lung, and brain. Helomics utilizes its Precision Cellular Analytical Platform and advanced bioinformatics to deliver personalized tumor profiles, aiding physicians in making informed treatment decisions. Its portfolio includes ChemoFx, which helps in selecting effective treatments for gynecologic cancer, and various biomarker tests like BioSpeciFx and GeneFx, designed to evaluate patient tumors at a molecular level. Additionally, Helomics offers tumor profiling services, patient-derived tumor models, and multi-omics assays, enhancing the precision of cancer care. The company collaborates with pharmaceutical and diagnostic firms to improve patient outcomes through tailored diagnostic solutions and insights, ultimately supporting better clinical decision-making in oncology.

NuPathe

Series B in 2008
NuPathe Inc. is a specialty pharmaceutical company dedicated to developing and commercializing innovative therapies for neurological and psychiatric disorders. The company's flagship product is Zecuity, a transdermal system utilizing sumatriptan for the acute treatment of migraines in adults. In addition to Zecuity, NuPathe is advancing a pipeline of product candidates, including NP201, designed for the continuous treatment of Parkinson's disease, and NP202, aimed at the long-term management of schizophrenia and bipolar disorder. Both candidates leverage the company's proprietary Long-Acting Delivery technology, which facilitates extended medication release through biodegradable implants. Founded in 2005 and based in Malvern, Pennsylvania, NuPathe operates as a subsidiary of Teva Pharmaceutical Industries Limited. The company actively seeks partnerships to enhance the commercial potential of its products in the United States and internationally.

Inspired Technologies

Series A in 2007
Inspired Technologies (North Huntingdon, PA) a commercial-stage medical device company focused on auto-titration of oxygen delivery for COPD patients.

Plextronics

Series B in 2007
Plextronics specializes in printed electronics. The company's focus is on organic light emitting diode (OLED) displays and lighting, specifically conductive inks and associated process technologies. Plextronic's technology will enable the mass production of these printed devices and therefore lower the cost.

NuPathe

Series A in 2006
NuPathe Inc. is a specialty pharmaceutical company dedicated to developing and commercializing innovative therapies for neurological and psychiatric disorders. The company's flagship product is Zecuity, a transdermal system utilizing sumatriptan for the acute treatment of migraines in adults. In addition to Zecuity, NuPathe is advancing a pipeline of product candidates, including NP201, designed for the continuous treatment of Parkinson's disease, and NP202, aimed at the long-term management of schizophrenia and bipolar disorder. Both candidates leverage the company's proprietary Long-Acting Delivery technology, which facilitates extended medication release through biodegradable implants. Founded in 2005 and based in Malvern, Pennsylvania, NuPathe operates as a subsidiary of Teva Pharmaceutical Industries Limited. The company actively seeks partnerships to enhance the commercial potential of its products in the United States and internationally.

Plextronics

Series A in 2006
Plextronics specializes in printed electronics. The company's focus is on organic light emitting diode (OLED) displays and lighting, specifically conductive inks and associated process technologies. Plextronic's technology will enable the mass production of these printed devices and therefore lower the cost.

Helomics

Funding Round in 2006
Helomics is a personalized healthcare company based in Pittsburgh, Pennsylvania, specializing in oncology insights and contract research services. The company focuses on six primary cancers: ovarian, breast, pancreatic, colon, lung, and brain. Helomics utilizes its Precision Cellular Analytical Platform and advanced bioinformatics to deliver personalized tumor profiles, aiding physicians in making informed treatment decisions. Its portfolio includes ChemoFx, which helps in selecting effective treatments for gynecologic cancer, and various biomarker tests like BioSpeciFx and GeneFx, designed to evaluate patient tumors at a molecular level. Additionally, Helomics offers tumor profiling services, patient-derived tumor models, and multi-omics assays, enhancing the precision of cancer care. The company collaborates with pharmaceutical and diagnostic firms to improve patient outcomes through tailored diagnostic solutions and insights, ultimately supporting better clinical decision-making in oncology.

CyOptics

Series F in 2005
CyOptics, Inc. specializes in the design, development, and marketing of Indium Phosphide (InP) optical chips and components, catering to access, metro, and long-haul communications systems. The company offers a range of products, including planar lightwave circuits (PLCs) for telecommunications and defense applications, as well as optical components such as transmitters, receivers, and modulators. These products serve as essential technology enablers for manufacturers of transmit optical sub-assemblies and receive optical sub-assemblies. Additionally, CyOptics provides contract design, foundry, and packaging services, along with radio frequency and optical design, wafer fabrication, and automated assembly and testing for both telecom and non-telecom applications. The company's clientele primarily consists of original equipment manufacturers and sub-system manufacturers in the communications sector. Founded in 1999 and headquartered in Breinigsville, Pennsylvania, CyOptics operates InP design and fabrication facilities in Lehigh Valley, Pennsylvania, silicon PLC fabrication operations in South Plainfield, New Jersey, and automated packaging and testing operations in Matamoros, Mexico.

Protez Pharmaceuticals

Series B in 2005
Protez Pharmaceuticals is a medical research company that discovers, develops, and commercializes antibiotics for difficult-to-treat hospital-based infections. The company focuses on differentiated intravenous and oral small molecule antibiotics to address bacterial resistant, and chronic or recurrent infections. Protez Pharmaceuticals was founded by Christopher M. Cashman in 2003 and is headquartered in Malvern, Pennsylvania.

Renal Solutions

Series B in 2005
Renal Solutions is focused on the development of dialysis products and services. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Renal Solutions was founded in 2000 and is based in Warrendale, Pennsylvania.

Eximias Pharmaceutical Corporation

Seed Round in 2004
Eximias Pharmaceutical Corporation is a healthcare and pharmaceutical company. It focuses on the acquisition, development, and commercialization of unique oncology and infectious disease products. The company has three novel, late-stage products, THYMITAQ(R) and ORATAQ(TM) for oncology, and MACROTAC(TM) for oncology and infectious disease. THYMITAQ(R), the company's flagship product, is being evaluated in a Phase III ETHECC(C) trial for the treatment of patients with unresectable liver cancer. Eximias Pharmaceutical Corporation was founded in 1997. The company was founded by YM BioSciences on April 1, 2006.

Helomics

Series C in 2003
Helomics is a personalized healthcare company based in Pittsburgh, Pennsylvania, specializing in oncology insights and contract research services. The company focuses on six primary cancers: ovarian, breast, pancreatic, colon, lung, and brain. Helomics utilizes its Precision Cellular Analytical Platform and advanced bioinformatics to deliver personalized tumor profiles, aiding physicians in making informed treatment decisions. Its portfolio includes ChemoFx, which helps in selecting effective treatments for gynecologic cancer, and various biomarker tests like BioSpeciFx and GeneFx, designed to evaluate patient tumors at a molecular level. Additionally, Helomics offers tumor profiling services, patient-derived tumor models, and multi-omics assays, enhancing the precision of cancer care. The company collaborates with pharmaceutical and diagnostic firms to improve patient outcomes through tailored diagnostic solutions and insights, ultimately supporting better clinical decision-making in oncology.

Entigo

Venture Round in 2003
Entigo specializes in enterprise warranty chain management solutions, providing businesses with tools to streamline warranty processing. Its primary offerings include Entigo Warranty, which facilitates the management of warranty claims, and Entigo Catalyst, designed for strategic assessments of existing warranty operations. The company also offers a range of services such as project management, implementation consulting, and systems integration. These solutions aim to automate the registration and claims process, reduce error rates, and enhance analytics for informed decision-making, ultimately improving product quality and minimizing warranty costs. Entigo's systems are tailored to meet the needs of Fortune 500 manufacturers across various sectors, including automotive, aerospace, and industrial equipment. Founded in 1995 and headquartered in Exton, Pennsylvania, Entigo is committed to optimizing warranty processes and ensuring seamless integration with warranty chain partners.

Renal Solutions

Series A in 2002
Renal Solutions is focused on the development of dialysis products and services. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Renal Solutions was founded in 2000 and is based in Warrendale, Pennsylvania.

Tissueinformatics

Venture Round in 2002
TissueInformatics, Inc. specializes in Tissue Information Solutions, a comprehensive suite of tools designed for the rapid capture, analysis, and mining of data derived from tissue samples. By utilizing its unique Quantf(x) technology platform, the company automates the identification and quantification of various tissue features, significantly enhancing the speed and accuracy of scientific research and development. This platform replaces traditional, subjective manual processes, offering a more efficient approach to tissue analysis. The solutions provided by TissueInformatics link archived high-resolution images with quantitative descriptions of tissue structure and function, facilitating flexible data analysis and correlation with other biological information. As a pioneer in the field of "tissue informatics," the company focuses on the objective analysis and recording of the components and organizational patterns of tissue features across human, plant, and animal samples, thereby advancing the understanding of tissue dynamics in various research contexts.

LogicLibrary

Seed Round in 2002
LogicLibrary, Inc. offers software and services designed to help enterprises manage and reuse their software development assets. The company specializes in technology that facilitates the creation, migration, and integration of enterprise applications, particularly within service-oriented architecture and web services. Among its key products is Logiscan, a code-scanning tool that aids architects, developers, and IT professionals in maintaining security throughout the software development lifecycle. Additionally, LogicLibrary provides Logidex, a software development asset mapping and discovery engine that visually represents enterprise application environments. Their services include implementation and installation of Logidex, strategic planning for service-oriented architecture and asset reuse, as well as training and support. Founded in 2000 and headquartered in Pittsburgh, Pennsylvania, LogicLibrary also has offices in Rochester, Minnesota, and Sunnyvale, California, serving Global 2000 enterprises. The company maintains strategic partnerships with major technology firms, enhancing its offerings and market reach.

Helomics

Series B in 2001
Helomics is a personalized healthcare company based in Pittsburgh, Pennsylvania, specializing in oncology insights and contract research services. The company focuses on six primary cancers: ovarian, breast, pancreatic, colon, lung, and brain. Helomics utilizes its Precision Cellular Analytical Platform and advanced bioinformatics to deliver personalized tumor profiles, aiding physicians in making informed treatment decisions. Its portfolio includes ChemoFx, which helps in selecting effective treatments for gynecologic cancer, and various biomarker tests like BioSpeciFx and GeneFx, designed to evaluate patient tumors at a molecular level. Additionally, Helomics offers tumor profiling services, patient-derived tumor models, and multi-omics assays, enhancing the precision of cancer care. The company collaborates with pharmaceutical and diagnostic firms to improve patient outcomes through tailored diagnostic solutions and insights, ultimately supporting better clinical decision-making in oncology.

Helomics

Series A in 2001
Helomics is a personalized healthcare company based in Pittsburgh, Pennsylvania, specializing in oncology insights and contract research services. The company focuses on six primary cancers: ovarian, breast, pancreatic, colon, lung, and brain. Helomics utilizes its Precision Cellular Analytical Platform and advanced bioinformatics to deliver personalized tumor profiles, aiding physicians in making informed treatment decisions. Its portfolio includes ChemoFx, which helps in selecting effective treatments for gynecologic cancer, and various biomarker tests like BioSpeciFx and GeneFx, designed to evaluate patient tumors at a molecular level. Additionally, Helomics offers tumor profiling services, patient-derived tumor models, and multi-omics assays, enhancing the precision of cancer care. The company collaborates with pharmaceutical and diagnostic firms to improve patient outcomes through tailored diagnostic solutions and insights, ultimately supporting better clinical decision-making in oncology.

Cerebellum Software

Venture Round in 2000
Cerebellum Software, developer technology for linking e-business applications with corporate data systems.

Helomics

Venture Round in 1998
Helomics is a personalized healthcare company based in Pittsburgh, Pennsylvania, specializing in oncology insights and contract research services. The company focuses on six primary cancers: ovarian, breast, pancreatic, colon, lung, and brain. Helomics utilizes its Precision Cellular Analytical Platform and advanced bioinformatics to deliver personalized tumor profiles, aiding physicians in making informed treatment decisions. Its portfolio includes ChemoFx, which helps in selecting effective treatments for gynecologic cancer, and various biomarker tests like BioSpeciFx and GeneFx, designed to evaluate patient tumors at a molecular level. Additionally, Helomics offers tumor profiling services, patient-derived tumor models, and multi-omics assays, enhancing the precision of cancer care. The company collaborates with pharmaceutical and diagnostic firms to improve patient outcomes through tailored diagnostic solutions and insights, ultimately supporting better clinical decision-making in oncology.

Neolinear

Venture Round in 1997
Neolinear is a developer ofsoftware for analog/mixed-signal silicon design. Neolinear's rapid analog design technology is critical for the consumer and communications markets where semiconductors are increasingly differentiated by their analog content.

Webmedx

Venture Round in 1996
Webmedx, Inc. provides medical documentation services. It offers transcription outsourcing solutions to support the clinical documentation needs of hospitals and clinics; and Webmedx Enterprise, a Web-native document and content management technology platform, which transforms physician dictation into clinical documentation possible for patient care and usable content for electronic health record applications. The company also provides QualityAnalytics, an Enterprise clinical documentation platform, which makes reporting quality measures easier and automates data abstraction for various types of queries, including Medicare's Recovery Audit Recovery (RAC) program. Webmedx, Inc. was formerly known as RadNet Corporation. The company was founded in 1996 and is headquartered in Atlanta, Georgia with additional offices in Nashville, Tennessee; Pittsburgh, Pennsylvania; and Spokane, Washington.

Safeguard Interactive

Venture Round in 1996
Safeguard Interactive provides online data storage and management solutions for consumers. It is based in Pittsburgh, Pennsylvania.

FreeMarkets

Venture Round in 1996
FreeMarkets provides software, services, and solutions to address the global supply management market. It enables companies to improve their sourcing, supply management processes, and enhance their supply management capacity. FreeMarkets’s solutions combine software, services, and information to help users lower costs and reduce their supply risks. Its sourcing solutions portfolio includes FreeMarkets GSM Solutions, FreeMarkets FullSource, FreeMarkets QS, FreeMarkets ES, and FreeMarkets Spend Visibility Solution. Glen T. Meakem co-founded FreeMarkets in 1995. The company was formerly known as Online Markets Corporation; and changed its name to and FreeMarkets OnLine, Inc. It further changed its name to FreeMarkets, Inc. in September 1999.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.